US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
イギリス
LSE
Compagnie du Bois Sauvage SA (0O9C) 銘柄情報

Compagnie du Bois Sauvage SA (0O9C)

399.00

0.00

(0.00%)

終了 7月11日 12:30AM

Compagnie du Bois Sauvage SA (0O9C) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

399.00

( - )

買値

399.00

売値

399.00

出来高

4

平均取引量 (3 か月)

459 €

財務取引量

-

0.00 日の範囲 0.00

399.00 52 週間の範囲 399.00

時価総額

企業価値

591.948M

前日終値

399.00

始値

-

時刻

最終取引時間

VWAP

-

歳入

336.72M

純利益

37.81M

発行済株式数

1,603,072

浮動株比率 (%)

47.54%

機関投資家保有比率 (%)

0.53%

配当利回り

8.6 (2.69%)

PER

13.06

株価売上高倍率 (PSR)

1.46

1 株当たり利益 (EPS)

23.51

ベータ

0.35

Compagnie du Bois Sauvage S.A., an investment holding company, invests in the chocolate, real estate, and investments sectors via private equity funds. It operates in Belgium, France, the United States of America, and internationally. Compagnie du Bois Sauvage S.A. was founded in 1957 and is based i... Compagnie du Bois Sauvage S.A., an investment holding company, invests in the chocolate, real estate, and investments sectors via private equity funds. It operates in Belgium, France, the United States of America, and internationally. Compagnie du Bois Sauvage S.A. was founded in 1957 and is based in Brussels, Belgium. 詳細を表示

セクター

Financials

業界

Financial Services

ウェブサイト

www.bois-sauvage.be

本社

Brussels, Belgium

設立

2026

Compagnie du Bois Sauvage SA is listed in the Financials sector of the ロンドン証券取引所 with ticker 0O9C. The last closing price for Compagnie du Bois Sauvage was 399.00 €. Over the last year, Compagnie du Bois Sauvage shares have traded in a share price range of 399.00 € to 399.00 €.

Compagnie du Bois Sauvage currently has 1,603,072 shares in issue. The market capitalisation of Compagnie du Bois Sauvage is 639.63 € million. Compagnie du Bois Sauvage has a price to earnings ratio (PE ratio) of 13.06.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	399	399	399	15	399	DE
52	0	0	399	399	399	6	399	DE
156	0	0	399	399	399	8	399	DE
260	0	0	399	399	399	6	399	DE

0O9C - Frequently Asked Questions (FAQ)

What is the current Compagnie du Bois Sauvage SA share price?

The current share price of Compagnie du Bois Sauvage SA is 399.00 €

How many Compagnie du Bois Sauvage SA shares are in issue?

Compagnie du Bois Sauvage SA has 1,603,072 shares in issue

What is the market cap of Compagnie du Bois Sauvage SA?

The market capitalisation of Compagnie du Bois Sauvage SA is EUR 639.63M

What is the 1 year trading range for Compagnie du Bois Sauvage SA share price?

Compagnie du Bois Sauvage SA has traded in the range of 399.00 € to 399.00 € during the past year

What is the PE ratio of Compagnie du Bois Sauvage SA?

The price to earnings ratio of Compagnie du Bois Sauvage SA is 13.06

What is the cash to sales ratio of Compagnie du Bois Sauvage SA?

The cash to sales ratio of Compagnie du Bois Sauvage SA is 1.46

What is the registered address of Compagnie du Bois Sauvage SA?

The registered address for Compagnie du Bois Sauvage SA is Rue du Bois Sauvage, 17, Brussels, Brussels, 1000

What is the Compagnie du Bois Sauvage SA website address?

The website address for Compagnie du Bois Sauvage SA is www.bois-sauvage.be

Which industry sector does Compagnie du Bois Sauvage SA operate in?

Compagnie du Bois Sauvage SA operates in the Financial Services sector

Sleepy$$$

Sleepy$$$ 28分前

Added a few k yesterday and bidding. Funny this one gets no attention. .07 - $15

Paul Brentjens

Paul Brentjens 34分前

yes, got that message too, yesterday morning.
Temporary error I guess, on CS..
Works again

WooptdooU

WooptdooU 36分前

Lwlg's No risk, Grifter, current leader has a greatest fear and the shorts seems to know the situation.
Whi would replace yves? Seems there are several who can spin the same wheels.

Teddytropics

Teddytropics 41分前

Thanks for showing yourself..

For new eyes, the linked material being presented as relevant is 4 years old from the Old CEO.

Currently he has nothing to do with the company and there has been zero evidence presented by;

The Pro-Bas

Mr79

https://media4.giphy.com/media/v1.Y2lkPTZjMDliOTUydTl4Ynh6azU1ZjkxeDd3YXgyb2FkOHF6ZXdqZHd3dHdueGJranM1NCZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9Zw/hwvbZ1kHDPdAs/giphy.gifhttps://media0.giphy.com/media/v1.Y2lkPTZjMDliOTUycTk4c3EzaWFoMm4xZTZjbXFieGFybGphZng0cW9uODZoeDZka2d4diZlcD12MV9pbnRlcm5hbF9naWZfYn

Nytoncva

Nytoncva 56分前

He may have already raised a chunk this past week, obviously not 9M, but anyone know what volume the first day was? Yesterday was less than average at only 700k. That really felt like dilution on day 1. Even with the poor PR, in this market environment I really would have expected more strength. I

Squirrely_McShitty

Squirrely_McShitty 1時間前

I assume you're talking smack to lower the price.

Yes, 432m shares outstanding with 600m authorized is simply horrible for an OTC company, lol. Claude Solitario is a bum too, aye?

Claude Solitario, for those who don't know, co-founded Invatec Health, a private company,

Nemesis18

Nemesis18 1時間前

If all was well, NWBO wouldn't have needed to do the latest 'data drag net' presentation. It smacks of a last desperate hail mary pass to satisfy both the MHRA and NICE forensic statisticians.

Nemesis18

Nemesis18 1時間前

>>Yep... all those people who had GBM and are alive 8, 10, 12 years later really agree with your opinion.... clown!!! 🙄

eagle8

eagle8 2時間前

Not that i know.

GLTU

DTGoody

DTGoody 2時間前

They're going to reverse merge with a Medical Courier Driver from PA to Deliver Anti-Depressants to the ENCC Shareholders who sold their shares right before a massive reverse merger happened! LOL :))

chereb19

chereb19 2時間前

This post is a good reminder that confidence and accuracy aren't the same thing. You predicted the FDA wouldn't "give the green light." The FDA subsequently approved the IDE to begin the human feasibility study. It's perfectly reasonable to remain skeptical, but it's also reasonable to acknowledge w

Wallstreeter$$$

Wallstreeter$$$ 2時間前

Typical lazy DD Norman cuz u wouldve seen I later said I would hold a core position in Vivos longer term. Btw numbnuts I've been swing trading this from day one, sometimes taking small profits but reinvesting most of it in new stock. Heck i've been increasing my position without spending one red cen

searay2701

searay2701 2時間前

I suggest that folks check BRC Laboratory com. A test has been completed on Insultex but it shows no completion date, could this one with no date on it be from an earlier testing than the one we are currently waiting for?

PickStocks

PickStocks 3時間前

Bill becomes law?

north40000

north40000 3時間前

“Cost-saving legislation in healthcare passed by German parliament didn’t help matters either.

murrayhill

murrayhill 3時間前

O'Jays - Backstabber
https://www.youtube.com/watch?v=RmXRQ3vfzcA

flipper44

flipper44 3時間前

Hi Baxers, I just don’t buy that a proposed refusal occurred followed by an appeal.

Perhaps this is one of those rare moments opposite forces align to try and make NWBO spill the beans.

Regardless, the way the system works, according to MHRA, is that CTBVEAG does not ma

janice shell

janice shell 3時間前

You know all the fuss that's being made about the tacky "Freedom Fuel" gas stations that have popped up in Southeast Pennsylvania and part of New Jersey...

All over the news for several days now. It's a mystery!! Who owns them? Some Trump buddy? Very likely, but oddly enough, nobody

shajandr

shajandr 3時間前

Dave:

Prison - you're nott gonna like big boy prison.

https://investorshub.advfn.com/uimage/uploads/2026/7/11/exmlgbeaumont.jpg
https://investorshub.advfn.com/uimage/uploads/2014/3/21/m[igcinmateArrival.jpg
https://investorshub.advfn.com/uimage/uploads/202

chereb19

chereb19 4時間前

Every time you're wrong, you don't revisit your thesis—you just invent a new one. First it was "they'll never get an IDE." Then it became "it's only an EFS IDE." Now it's dilution, patents and OTC. The conclusion never changes; only the excuse does.

You're throwing everything at the w

Compagnie du Bois Sauvage

Mitsu Hc Cap 24

Dermata Therapeutics

United Utilities Water F...

3R Games SpolkaAkcyjna

Frigorifico Araputanga S... PNA

Vanguard FTSE All-World ...

Iervolino Entertainment

BlackRock Institutional ...

Hyundai Elevator (PK)

Altamira Therapeutics (ID)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。